
Tilray Brands, Cronos Group, and Canopy Growth are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies whose primary business involves the cultivation, production, distribution, or ancillary services (e.g., biotech, retail, equipment, or compliance) related to cannabis and hemp products. For investors, these stocks are often characterized by higher regulatory risk, sector volatility, and sensitivity to changes in legalization, public policy, and consumer demand. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Tilray Brands (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
Cronos Group (CRON)
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Read Our Latest Research Report on CRON
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Read Our Latest Research Report on CGC
See Also
- MarketBeat’s Top Five Stocks to Own in December 2025
- Apple Stock Could Surge on Record iPhone Sales and Bold AI Strategy
- Dividend Growth Is Heating Up: 3 Stocks With Steady Payout Gains
- Why AutoZone’s Stock Drop Could Be a Golden Buying Opportunity
- Ollie’s Bargain Outlet Hits Rock-Bottom in Q4: Buy the Dip?
- Insiders Are Selling These 3 Stocks—Here’s Why
